K

KPX Lifescience Co Ltd
KOSDAQ:114450

Watchlist Manager
KPX Lifescience Co Ltd
KOSDAQ:114450
Watchlist
Price: 3 025 KRW -1.31% Market Closed
Market Cap: ₩60.5B

Net Margin

-1.1%
Current
Improving
by 24.1%
vs 3-y average of -25.1%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-1.1%
=
Net Income
₩-365.5m
/
Revenue
₩34.7B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-1.1%
=
Net Income
₩-365.5m
/
Revenue
₩34.7B

Peer Comparison

Country Company Market Cap Net
Margin
KR
KPX Lifescience Co Ltd
KOSDAQ:114450
57.7B KRW
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
230.9B USD
Loading...
US
Danaher Corp
NYSE:DHR
160.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
82.9T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.9B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.7B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.7B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.1B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.7B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR
Loading...

Market Distribution

In line with most companies in Korea
Percentile
34th
Based on 2 632 companies
34th percentile
-1.1%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

KPX Lifescience Co Ltd
Glance View

KPX LIFESCIENCE Co., Ltd. engages in the production and sale of pharmaceutical and agricultural raw materials and intermediates. The company is headquartered in Yeosu, Jeollanam-Do and currently employs 61 full-time employees. The company went IPO on 2009-12-22. The Company’s products consist of AMZ and CCIM, which are used as crop protection materials; EDP-CL, which is a antibiotic used as ingredient of piperacillin; PM06, which is used for treatment of allergic diseases, and DSIC, which is used as pharmaceutical intermediate. The firm also provides antibiotics and others. The firm distributes its products within domestic market and to overseas markets, including Japan, the United States, Europe and others.

Intrinsic Value
2 699.3 KRW
Overvaluation 11%
Intrinsic Value
Price
K
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-1.1%
=
Net Income
₩-365.5m
/
Revenue
₩34.7B
What is KPX Lifescience Co Ltd's current Net Margin?

The current Net Margin for KPX Lifescience Co Ltd is -1.1%, which is above its 3-year median of -25.1%.

How has Net Margin changed over time?

Over the last 3 years, KPX Lifescience Co Ltd’s Net Margin has increased from -5.7% to -1.1%. During this period, it reached a low of -73.1% on Dec 31, 2023 and a high of 6.3% on Dec 31, 2024.

Back to Top